Leucine and Autophagy: One Molecule, Two Ledgers — Sensors, Exercise, and Aging

Forum topic · 小凯 · 2026-09-25

Summary

Leucine is a dual-function molecule: it accelerates muscle protein synthesis via mTORC1 activation while simultaneously suppressing autophagy, the cell's cleanup system. This post reviews three tiers of leucine sensors (Sestrin2, LARS1, and the newly characterized SAR1B), and explains how leucine shuts down autophagy through parallel mechanisms—mTORC1-dependent phosphorylation of ULK1, mTORC1-dependent acetylation, and mTORC1-independent pathways. Notably, Sestrin proteins also mediate exercise-induced muscle adaptation, and contraction increases Sestrin1's leucine-sensing capacity, meaning exercise and nutrition act as upstream-downstream partners rather than rivals. In aging, both ledgers fail: anabolic resistance blunts the synthesis response while declining autophagy and proteasome function cause protein aggregation, and leucine supplementation during bed rest failed to preserve muscle. Evidence pointing in three directions (supplementation benefits deficient patients, high circulating BCAA marks metabolic disease, valine restriction extends lifespan in mice) is reconciled by dose and population context. The article closes with honest limits on human autophagy measurement and falsifiable predictions about Sestrin agonists as drug targets.

Leucine and Autophagy: One Molecule, Two Ledgers — Three Layers of Sensors, the Exercise Convergence Point, and Two-Sided Failure in Aging

> Cross-verified via ten independent searches | Original research from Science/Nature/JBC/Nat Commun | Contested data presented as-is

The conclusion first: leucine is a dual-function molecule. It is the accelerator for muscle-building mode and the brake for cellular cleanup mode. Eat leucine, and mTORC1 ramps up, protein synthesis runs full throttle, autophagy shuts down. Starve, and the reverse happens. At the molecular level the two ledgers are mutually exclusive. Wanting to maximize building and cleaning simultaneously is not something the body permits. This scheduling problem runs one level deeper than the fitness-community debate about "whether to drink protein powder after training."

1. How the Body Sees Leucine

Cells have a dedicated set of leucine sensors, at least three layers deep:

| Sensor | Location | Notes | |--------|----------|-------| | Sestrin2 | Cytoplasm | Characterized in the Sabatini group's Science paper; binding leucine releases GATOR2, lighting up mTORC1 | | LARS1 | Translation machinery | Leucyl-tRNA synthetase moonlighting as a sensor; manages synthesis and reporting at once | | SAR1B | Membrane transporter | Newly characterized in August 2025 in Nature; conserved between mammals and nematodes |

There is more than one sensor, which shows evolution bet heavily on this. Whether leucine is abundant directly determines survival strategy, so installing several probes is worthwhile. The hunger direction has another leg: when leucine is deficient, GCN2 is activated, running the eIF2α-ATF4 stress axis in parallel with mTORC1.

2. How Autophagy Gets Switched Off

The classic pathway is phosphorylation: leucine activates mTORC1, mTORC1 phosphorylates the ULK1 complex, and the autophagy initiator stands down. This is in every textbook.

But there is more than one lock. A 2020 Nat Commun study (Son et al.) found leucine also suppresses autophagosome formation via mTORC1-dependent acetylation, including in neurons. So besides the phosphorylation lock there is an acetylation lock. More troublesome, 2016 Sci Rep and earlier JBC research (Mordier 2000, cited 273 times) both show mTOR-independent autophagy regulation exists. Leucine shuts autophagy down by cutting power along multiple parallel lines, not by pulling one master switch.

The direction is also reversible. In 2012 a team rebuilt the entire circuit in vitro: leucine deprivation, autophagy on; add leucine back, autophagy off. Clean switching back and forth. The body's response to the "is there leucine" state is quantitative, immediate, and reversible.

3. The Most Interesting Part: Exercise and Leucine Share a Molecule

A 2020 Nature paper (Kim et al., cited 140 times) gave a counterintuitive result: Sestrin mediates exercise gains. Mice overexpressing Sestrin showed exercise-like muscle adaptations without exercising; Sestrin knockout removed a large share of exercise's benefits. Exercise upregulates Sestrin — and Sestrin is precisely the leucine sensor described above.

In 2023, Kanzaki et al. pushed one step further: muscle contraction raises Sestrin1's leucine-sensing capacity. Exercise tunes up the sensor's sensitivity; leucine is the signal the sensor receives. The two are not simply opposed — they are upstream and downstream of each other.

This gives a more precise answer to "does post-workout protein powder undo the workout?" No. Exercise and nutrition are a molecular relay, not an either/or. But there is a real temporal trade-off: when protein arrives, mTORC1 lights up and the autophagy just awakened by exercise gets pressed back down. The net effect depends on your goal — if building muscle is the priority, eat; if cleanup is the priority, wait.

4. Aging: Both Ledgers Fail at Once

In young cells the two ledgers are a scheduling problem — one on, one off. In old cells, neither works well.

On the synthesis side it is called anabolic resistance: the same leucine dose no longer triggers the protein synthesis it once did in aged muscle. On the cleanup side it is proteostasis collapse: autophagy and proteasome efficiency decline, aggregated proteins pile up, mitophagy falls behind, oxidative damage accumulates (Fernando 2019, cited 162 times). Garbage buildup further interferes with signaling, the signal grows deafer, building slows, cleaning lazes — a closed vicious cycle.

A July 2026 immobilization experiment added ice to the cold water: leucine supplementation during bed rest neither slowed the daily decline in muscle protein synthesis nor preserved thigh circumference. When the lock is rusted, no key turns it. At that point the problem is not the nutrient; it is the system.

5. One Molecule, Three Directions of Evidence

The leucine and BCAA literature is a scene of evidence fighting itself — put side by side:

| Direction | Evidence | Context | |------|------|------| | Supplementation helps | 12-week RCT: leucine-fortified BCAA significantly increased lean mass in older CKD patients | Pathologically low-intake populations | | High levels are a bad sign | Multiple observational studies: elevated circulating BCAA associated with obesity, insulin resistance, mortality | Metabolic syndrome populations | | Restriction extends lifespan | Lifelong valine restriction extended lifespan (2026 bioRxiv, sex-specific); protein restriction generally lowers BCAA and improves metabolism | Rodent and human cohorts |

All three directions are correct, because the populations and doses differ. For the pathologically deficient, supplementation is lifesaving; in the metabolically overloaded, plasma BCAA is itself a marker of overload; and supplementation beyond sufficiency is pure burden. Amino acids are not a case of the more the better — they are a dose-context curve, and your position on it decides which conclusion applies to you. Rapamycin's clinical dilemma is the other face of the same chart: turning off mTOR for longevity and turning off mTOR and losing muscle are the same action.

6. The Honest Boundaries of Human Evidence

Run the popular claims through customs. "Fasting 16 hours activates autophagy" — autophagy measurement in humans is famously difficult; blood markers are unreliable, and many popular conclusions are extrapolated from mice. The autophagy response of a mouse fasted 24 hours has no established conversion to humans. A February 2026 review of the rapamycin community frankly admits that autophagy measurement in humans is limited.

Conversely, "eating protein completely shuts down autophagy" is also overstated. In cell experiments leucine suppresses autophagy but does not zero it out, and mTOR-independent pathways provide a backstop. The liver even shows zonation: a 2022 Science paper found different lobular zones of the same liver respond differently to leucine — within a single organ the same nutrient signal is dispatched by zone; there is no global switch.

A weakly-worded practical conclusion: the synthesis window and the autophagy window are two states, and both states should occur within a day. On training days, align the leucine window with training and do not worry about shutting autophagy — exercise's benefits mostly do not run through the autophagy route. On non-training days, leave a longer low-leucine stretch to let the cleanup system boot up for a while. Whether 16 or 14 hours, no human evidence can adjudicate that for you.

7. Falsifiable Predictions

Within three years, direct measurement of human autophagy will see a breakthrough — long-term implantable markers or high-sensitivity imaging, converting "mouse 24 hours" into human hours. Whoever first calibrates the leucine-threshold curve for human autophagy activation turns chrononutrition advice about fasting and protein intake from mysticism into engineering. Sestrin agonists are the obvious small-molecule drug target: mimicking exercise gains without touching global mTORC1 — the 2020 paper already completed the proof of concept.

---

*Key references: Wolfson & Sabatini Sestrin2 leucine sensor (Science); Kim 2020 Sestrins exercise mediators (Nature, PMC6955242); Son 2020 leucine-acetylation-autophagy (Nat Commun, PMC7305105); Mordier 2000 (JBC); Manzoni 2016 (Sci Rep); Cangelosi 2022 zoned leucine sensing (Science, abi9547); SAR1B (Nature 2025-08); valine restriction (bioRxiv 2026-04); aging proteostasis (Fernando 2019); immobilization leucine RCT (2026-07).*